Skip to main content
. 2023 Aug 30;72(11):3755–3764. doi: 10.1007/s00262-023-03527-y

Table 1.

Patients' characteristics (n = 63)

Age (y.o.) (median, range) 70, 49–83
Gender, n (%)
 Male 45 (71.4)
 Female 18 (28.6)
Smoking habits, n (%)
 Never 16 (25.4)
 Current/formaer 47 (74.6)
Pathology, n (%)
 Adenocarcinoma 43 (68.2)
 Squamous cell ca 17 (27.0)
 Adeno-squamous cell ca 1 (1.6)
 Pleomorphic 2 (3.2)
 Tumor size (mm) (median, range) 25, 9–137
Cell grade, n (%)
 Grade 1 28 (44.4)
 Grade 2 19 (30.2)
 Grade 3 16 (25.4)
Pathological stage, n (%)
 1A 36 (57.1)
 1B 11 (17.5)
 2A 5 (7.9)
 2B 0 (0.0)
 3A 9 (14.3)
 4 2 (3.2)
Invasion to lymphatics, n (%) 27 (42.9)
Invasion to microvessels, n (%) 42 (66.7)